FDA Drug Recalls
14,801 recalls, newest first
Class II · Moderate risk Terminated Apr 23, 2024
Reason CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity…
Class II · Moderate risk Terminated Apr 23, 2024
Reason CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity…
Class I · High risk Terminated Apr 22, 2024
Reason Marketed Without An Approved NDA/ANDA
Class III · Low risk Terminated Apr 2, 2024
Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration…
Class III · Low risk Terminated Apr 2, 2024
Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration…
Class II · Moderate risk Terminated Mar 29, 2024
Reason CGMP Deviations
Class I · High risk Terminated Mar 28, 2024
Reason Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Class II · Moderate risk Terminated Mar 27, 2024
Reason CGMP Deviations
Class II · Moderate risk Terminated Mar 26, 2024
Reason Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Class III · Low risk Terminated Mar 25, 2024
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated Mar 22, 2024
Reason Lack of assurance of sterility: bags have the potential to leak..
Class I · High risk Terminated Mar 21, 2024
Reason Superpotent Drug: Due to overfilling of drug powder
Class II · Moderate risk Terminated Mar 21, 2024
Reason Subpotent Drug
Class II · Moderate risk Terminated Mar 21, 2024
Reason cGMP Diviations
Class II · Moderate risk Terminated Mar 7, 2024
Reason Failed Dissolution Specifications
Class II · Moderate risk Terminated Mar 6, 2024
Reason Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label…
Class II · Moderate risk Terminated Mar 5, 2024
Reason Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
Class III · Low risk Terminated Mar 4, 2024
Reason Cross Contamination with Other Products:(mycophenolate mofetil).
Class II · Moderate risk Terminated Feb 22, 2024
Reason Failed Stability Specification: Water determination was found not complying with specification.
Class II · Moderate risk Terminated Feb 19, 2024
Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class II · Moderate risk Terminated Feb 19, 2024
Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class II · Moderate risk Terminated Feb 19, 2024
Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class II · Moderate risk Terminated Feb 19, 2024
Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class II · Moderate risk Terminated Feb 19, 2024
Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Class II · Moderate risk Terminated Feb 13, 2024
Reason Failed Impurities/Degradation Specifications: Out-of-specification test results.